Neuroprotective strategies for multiple sclerosis (NeuroproMiSe) is an Integrated Project of the European Union's Sixth Framework Programme. It is part of the priority program on Life Sciences, Genomics and Biotechnology for Health which aims to advance medicine and quality of life for European citizens.
The key aim of NeuroproMiSe is to identify genetic risk factors and pathological mechanisms of multiple sclerosis and to provide new bio-therapeutic compounds to cure chronic neuroimmune diseases.
Login to access the 'Members only' area.
NeuroproMiSe is built upon a consortium of 20 European research groups active in the fields of neuroinflammatory diseases, neurodegeneration, genetics, basic neuroscience and immunology.
NeuroproMiSe promotes training and mobility and provides opportunities for basic and clinical researchers across Europe.
Multiple sclerosis is a chronic inflammatory disease of the central nervous system and the most common cause of neurological disability in young and middle-aged adults in the Western world.
[No contents are available at this time. You can browse the Archive by following this link]
[A] About NeuroproMiSe :: [B] About us :: [C] About multiple sclerosis [E] Research :: [E] Training and Careers :: [F] Events [G] Members [I]Information :: [R] Search :: [K] Contact us :: [W] Link [H] Home :: [S] Back to ISS Home :: [V] Accessibility
[J] Italian :: [Y] English
CSS: medium characters :: BIG CHARACTERS :: Printer friendly version of this page
RSS: Subscribe the RSS for this WebSite and you'll be informed when there's something new
© - Istituto Superiore di Sanità Viale Regina Elena 299 - 00161 - Roma (I) Partita I.V.A. 03657731000 [L] Legal information - Privacy
